SRZN · Surrozen Inc
United States · RS rating 87 · As of 2026-11-03
| Price | 30.12 USD |
|---|---|
| 1-day change | +3.8% |
| RS rating (overall / 1M / 3M / 12M) | 87 / 67 / 94 / 95 |
| Stage | Advancing |
| Composite / Minervini / CANSLIM score | 47 / 60 / 58 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +96.5% |
| Sales growth Q/Q | -46.3% |
| Distance from 52-week high | +11.8% |
| Market cap (USD) | $360.3M |